glucose, (beta-d)-isomer has been researched along with Candidiasis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 10 (58.82) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Carreras, E; Català, C; Lozano, F; Orta-Mascaró, M; Simões, IT; Velasco de Andrés, M; Zaragoza, O | 1 |
Arm, JP; Balestrieri, B; Gelb, MH; Katz, HR; Maekawa, A; Xing, W | 1 |
Hendriks, T; Joosten, LA; Kullberg, BJ; Netea, MG; van de Veerdonk, FL; van der Meer, JW; Verschueren, IC | 1 |
Aliprantis, A; Glimcher, LH; Greenblatt, MB; Hu, B | 1 |
Brown, GD; Faro-Trindade, I; Hadebe, S; Kerrigan, AM; Lang, DM; Redelinghuys, P; Reid, DM; Srinivasan, N; Steele, C; Wainwright, H; Willment, JA | 1 |
Clark, RA; Szot, S | 1 |
Bistoni, F; Monari, C; Palazzetti, B; Pietrella, D; Retini, C; Vecchiarelli, A | 1 |
Boerman, OC; Corstens, FH; Laverman, P; Oyen, WJ; van de Ven, MT; van der Laken, CJ; van der Meer, JW | 1 |
Cases-Corona, C; Fernandez-Juarez, G; Gonzalez-Lopez, A; Lucena, R; Martin-Segarra, O; Moreno de la Higuera, MA; Shabaka, A | 1 |
Athan, E; Bartolo, C; Friedman, ND; Fuller, A; Hall, V; Lanyon, C; Morrissey, CO | 1 |
Kong, X; Leng, D; Liang, G; Liu, W; Lu, G; Shen, Y; Shi, D; Wang, Q; Zhang, H; Zheng, H | 1 |
Fukazawa, M; Hiramatsu, M; Honda, K; Kawabe, Y; Matsumoto, M; Suzuki, M; Suzuki, Y | 1 |
Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J | 1 |
Chang, CL; Chung, CY; Lai, SK; Liang, CL; Liu, HY; Yang, WC | 1 |
Jančinová, V; Karelin, AA; Nifantiev, NE; Paulovičová, E; Paulovičová, L; Pilišiová, R; Tsvetkov, YE; Yashunsky, DV | 1 |
Choi, JY; Han, Y; Jang, EC; Kang, SS; Kim, SY; Kim, YS; Lee, JH; Lee, JY; Lee, SH; Park, JH | 1 |
Lee, DG; Park, C; Woo, ER | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Candidiasis
Article | Year |
---|---|
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.
Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osmotic; Double-Blind Method; Drug Therapy, Combination; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Thiophenes; Treatment Outcome; Triazoles; Weight Loss | 2014 |
16 other study(ies) available for glucose, (beta-d)-isomer and Candidiasis
Article | Year |
---|---|
Discordant susceptibility of inbred C57BL/6 versus outbred CD1 mice to experimental fungal sepsis.
Topics: Animals; Animals, Outbred Strains; Bacterial Outer Membrane Proteins; Candida albicans; Candidiasis; CD5 Antigens; Cytokines; Disease Models, Animal; Disease Susceptibility; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mycoses; Sepsis; Species Specificity; Spleen; Teichoic Acids; Zymosan | 2019 |
Group V secretory phospholipase A2 modulates phagosome maturation and regulates the innate immune response against Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Group V Phospholipases A2; Immunity, Innate; Lectins, C-Type; Macrophages; Membrane Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Phagocytosis; Phagosomes; Survival Rate; Tumor Necrosis Factor-alpha; Zymosan | 2009 |
Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure.
Topics: Animals; Candidiasis; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Interleukin-10; Interleukin-17; Mice; Mice, Knockout; Multiple Organ Failure; Phagocytosis; Signal Transduction; Tumor Necrosis Factor-alpha; Zymosan | 2010 |
Calcineurin regulates innate antifungal immunity in neutrophils.
Topics: Animals; Antifungal Agents; beta-Glucans; Calcineurin; Candida albicans; Candidiasis; Cyclosporine; Disease Susceptibility; Homeostasis; Humans; Immunity, Innate; Immunosuppressive Agents; Mice; Mycoses; Neutrophils; Polysaccharides, Bacterial; Zymosan | 2010 |
Characterisation of innate fungal recognition in the lung.
Topics: Animals; Antigens, Fungal; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida albicans; Candidiasis; Female; Host-Pathogen Interactions; Immunity, Innate; Lectins, C-Type; Lung Diseases, Fungal; Lysosomes; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Phagocytosis; Phagosomes; Pneumonia; Protein Binding; Pulmonary Aspergillosis; Pulmonary Surfactants; Receptors, Immunologic; Spores, Fungal; Zymosan | 2012 |
Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
Topics: Aminopeptidases; Candidiasis; Catalysis; Chemotactic Factors; Complement C5; Complement C5a; Granulomatous Disease, Chronic; Humans; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Peroxidase; Peroxidases; Sulfides; Tetradecanoylphorbol Acetate; Zymosan | 1982 |
Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes.
Topics: Acids; AIDS-Related Opportunistic Infections; Antibodies, Blocking; Candidiasis; CD4 Antigens; Cells, Cultured; Cryptococcosis; Cytotoxicity Tests, Immunologic; HIV Envelope Protein gp120; HIV-1; Humans; Lysosomes; Monocytes; Phagocytosis; Phagosomes; Recombinant Proteins; Superoxides; Zymosan | 1998 |
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
Topics: Animals; Candida albicans; Candidiasis; Escherichia coli Infections; Humans; Inflammation; Interleukin-1; Mice; Neutropenia; Polymerase Chain Reaction; Receptors, Interleukin-1; Recombinant Proteins; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Transcription, Genetic; Turpentine; Zymosan | 1998 |
Fulminant Emphysematous Pyelonephritis by Candida glabrata in a Kidney Allograft.
Topics: Allografts; Benzhydryl Compounds; Candida glabrata; Candidiasis; Female; Glucosides; Humans; Kidney Transplantation; Middle Aged; Nephrectomy; Pyelonephritis | 2020 |
Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
Topics: Aged; Benzhydryl Compounds; Candidiasis; Diabetes Mellitus, Type 2; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Male; Middle Aged; Pharmaceutical Preparations; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Paeoniflorin augments systemic Candida albicans infection through inhibiting Th1 and Th17 cell expression in a mouse model.
Topics: Animals; Candida albicans; Candidiasis; Cytokines; Disease Models, Animal; Glucosides; Kidney; Liver; Mice, Inbred BALB C; Monoterpenes; Spleen; Th1 Cells; Th17 Cells | 2018 |
Effect of SGLT2 inhibitors in a murine model of urinary tract infection with Candida albicans.
Topics: Animals; Benzhydryl Compounds; Canagliflozin; Candida albicans; Candidiasis; Disease Progression; Female; Glucosides; Glycosuria; Kidney; Mice; Mice, Inbred C57BL; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Urinary Tract Infections | 2014 |
Cytopiloyne, a polyacetylenic glucoside from Bidens pilosa, acts as a novel anticandidal agent via regulation of macrophages.
Topics: Animals; Antifungal Agents; Bidens; Candidiasis; Carrageenan; Cell Line; Female; Glucosides; Liver; Lysosomes; Macrophages; Mice, Inbred BALB C; Phagocytosis; Phytotherapy; Polyynes; Protein Kinase C; Spleen | 2016 |
The evaluation of β-(1 → 3)-nonaglucoside as an anti-Candida albicans immune response inducer.
Topics: Animals; Antibodies, Fungal; Antigens, Fungal; Candida albicans; Candidiasis; Cell Count; Cell Proliferation; Female; Fungal Polysaccharides; Glucosides; Hyphae; Immunity, Humoral; Mice; Mice, Inbred BALB C; RAW 264.7 Cells; Vaccination | 2016 |
Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.
Topics: Adoptive Transfer; Animals; Anti-Infective Agents; Antibodies, Blocking; Candida albicans; Candidiasis; Colony Count, Microbial; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Flavanones; Glucosides; Glycyrrhiza; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Roots; Th1 Cells | 2009 |
Anti-Candida property of a lignan glycoside derived from Styrax japonica S. et Z. via membrane-active mechanisms.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Colony Count, Microbial; Diphenylhexatriene; Energy Metabolism; Fluorescent Dyes; Glucosides; Humans; Lignans; Magnetic Resonance Spectroscopy; Mycelium; Plant Bark; Plant Extracts; Styrax | 2010 |